Your browser does not support JavaScript!

FranceBiotechnologies

FranceBiotechnologies est une plateforme pour découvrir les actualités, entreprises, produits et savoir-faire techniques de la biotechnologies. Partagez et échangez entre spécialistes.

Rejoignez la communauté
Vous devez être connecté en tant qu'entreprise pour exporter en PDF
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 12:12
Can gene therapy treat vision loss?
Since the approval of Luxturna, there has been a wave of companies developing treatments with the potential to cure different forms of genetic blindness. The post Can gene therapy treat vision loss?...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 08:34
Behind the Cure51 deal: Is NVIDIA becoming biotech’s AI infrastructure?
On the occasion of its deal with Cure51, find out about NVIDIA's biotech strategy as it gets more and more involved in the industry. The post Behind the Cure51 deal: Is NVIDIA becoming biotech’s...
www.labiotech.eu
Une question a été posée - Il y a 2 jours
1 activité(s)
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 3 jours
First antibiotic in 50 years to tackle superbug nears approval: what’s going on in the field?
Antibiotic development has seen a slump in recent decades. Now, after 50 years, a new antibiotic has been created to tackle bacterial infections. The post First antibiotic in 50 years to tackle...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours
Corporate venture capital and biotechnology in 2025: challenges, opportunities, and threats
This week, Paolo Di Giorgio and Regina Hodits of Angelini Ventures share their perspective on the current fundraising landscape. The post Corporate venture capital and biotechnology in 2025:...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours
Beyond CRISPR: What CAST could bring to genome editing
Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in research. The post Beyond CRISPR: What CAST could bring to genome editing...
www.labiotech.eu
Une question a été posée - Il y a 1 semaine
1 activité(s)
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine
ASCO 2025: key highlights in cancer therapeutics
Discover the major highlights from ASCO, according to researchers and drug developers who attended the convention. The post ASCO 2025: key highlights in cancer therapeutics appeared first on...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine
The biggest biotech funding rounds in May 2025
The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in May 2025. The post The biggest biotech funding rounds in May 2025 appeared...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine
How biotechs are developing novel treatments to tackle high cholesterol
Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets. The post How biotechs are developing novel treatments to tackle high...
www.labiotech.eu
Charger plus d'actualités